| The reason of the increase (decrease) in the sales/ revenues during the current year compared to the last year | SMC generated net revenue of SAR 1,538.5 million, up 7.0% from SAR 1,437.8 million in FY 2024. Growth was delivered during a strategic transition year marked by the accelerated shift away from LTC toward high-performing acute inpatient services and outpatient clinic services. The rollout of 57 clinics during the year (41 in H1 2025 and 16 in Q4 2025) and their subsequent ramp-up resulted in significant outpatient revenue growth, while high margin acute admissions and improved utilization drove an increase in inpatient revenue. |
| The reason of the increase (decrease) in the net profit during the current year compared to the last year is | Net profit in FY 2025 rose 43.7% YoY to SAR 266.2 million from SAR 185.2 million in FY 2024, with net margin improving to 17.3% from 12.9% over the year, underscoring the structural benefits and operating leverage of scaling acute and outpatient operations, in addition to a record fourth quarter offset earlier restructuring costs, IPO-related expenses, and one-off items incurred during the year. FY 2025 net income was also driven by a SAR 60.6 million gain on sale of the land related to the Al Wadi Real Estate Fund. |
| Statement of the type of external auditor's report | Unmodified opinion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | NA |
| Reclassification of Comparison Items | Certain prior year amounts have been reclassified to conform to the current year’s presentation. |
| Additional Information | NA |
| Attached Documents | Attached Documents |
